GL Ventures Leads China PEs in Immunotherapy Development
07 May 2026
US$ 20.00
GL Ventures has led the US$38 m financing round of LTZ Therapeutics, with follow-on capital from Boyu Growth Ventures,...
Related Publications
Subscribers’ Weekly for the week ending 8 May 2026...
Listen to Subscribers' Weekly 08 May 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.